相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ADDITION OF BEVACIZUMAB TO STANDARD RADIATION THERAPY AND DAILY TEMOZOLOMIDE IS ASSOCIATED WITH MINIMAL TOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
James J. Vredenburgh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II study of sunitinib malate in patients with recurrent high-grade glioma
B. Neyns et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib
Alfredo Carrato Mena et al.
ANTI-CANCER DRUGS (2010)
Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction
Oren Z. Lerman et al.
BLOOD (2010)
Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance
Candice A. Shaifer et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib
Manik Chahal et al.
NEURO-ONCOLOGY (2010)
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma
Joost J. C. Verhoeff et al.
EUROPEAN JOURNAL OF CANCER (2009)
SAFETY AND EFFICACY OF BEVACIZUMAB WITH HYPOFRACTIONATED STEREOTACTIC IRRADIATION FOR RECURRENT MALIGNANT GLIOMAS
Philip H. Gutin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
Hui-Fang Li et al.
RADIATION ONCOLOGY (2009)
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy
Carmen Timke et al.
CLINICAL CANCER RESEARCH (2008)
Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma
Vicki L. Goodman et al.
CLINICAL CANCER RESEARCH (2007)
Food and drug administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma
Edwin P. Rock et al.
ONCOLOGIST (2007)
Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec®)
Susanne Oertel et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2006)
Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells
ML Li et al.
BMC CANCER (2006)
Radiation combined with antiangiogenic and antivascular agents
MS O'Reilly
SEMINARS IN RADIATION ONCOLOGY (2006)
Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines - a clue to radioresistance?
KE Hovinga et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition
D Zips et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Differential regulation of VEGF, HIF1α and angiopoietin-1,-2 and-4 by hypoxia and ionizing radiation in human glioblastoma
EL Lund et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium
B Lu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels
HH Steiner et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways
P Wachsberger et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Glioblastoma cells block radiation-induced programmed cell death of endothelial cells
CK Brown et al.
FEBS LETTERS (2004)
Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms
R Erber et al.
FASEB JOURNAL (2003)
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
G Bergers et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells
K Mori et al.
FREE RADICAL RESEARCH (2000)
分享论文
